Sustainability officer

PD Dr. med. Simona Schlereth

Dr. med. Simona Schlereth

Department of Ophthalmology
University Hospital Cologne
Kerpener Str. 62
50937 Cologne, Germany
+49 221 478 98896
simona.schlereth@uk-koeln.de

Projects:

Project leader

B04, C04, Z04

Scientific career

Since 2022 Senior physician, University Hospital of Cologne, Department of Ophthalmology

Dec. 2016 Specialist in Ophthalmology (“Deutscher Facharzt für Augenheilkunde”), since 2018 „Funktionsoberärztin“ at the University Hospital of Cologne, Department of Ophthalmology

May 2016 Fellow of the European Board of Ophthalmology (FEBO)

2011- 2016 Specialist training at the University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Ophthalmology

Feb-Dec. 2010 Research stay at the Schepens Eye Research Institute Boston, Harvard Medical School in the laboratory of Prof. Dana, Boston, USA

Prizes and honors

2022 Research award from the “Verein Rheinisch Westfälischer Augenärzte“

2016 Research award from the „ Eye Foundation of the German

2016 Research rotational position by FOR2240

2014 Gabriele Lederle foundation

2013 Research funding by Cologne Gerok program

2013 Travel Grant der Women in Eye & Vision Research to the ARVO- conference in Seattle, USA

2012 Henning Zügel Prize for basic research in Ophthalmology

Selected publications

  1. Peil J, Vossen C, Bock F, Clahsen T, Schiller P, Heindl LM, Bosch JJ, Wunderlich FT, Cursiefen C, Schlereth SL.: Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma. J Immunol. 2023 Dec 15:ji2300063. doi:10.4049/jimmunol.2300063
  2. Vernin A, Schrittenlocher S, Matthaei M, Roters S, Siebelmann S, Bachmann B, Schiller P, Cursiefen C, Schlereth SL. Excimer Laser Phototherapeutic Keratectomy for Anterior Corneal Opacification After Descemet Membrane Endothelial Keratoplasty. Cornea. 2024 Jan 1;43(1):95-104.
  3. Clahsen T, Hadrian K, Notara M, Schlereth SL, Howaldt A, Prokosch V, Volatier T, Hos D, Schroedl F, Kaser-Eichberger A, Heindl LM, Steven P, Bosch JJ, Steinkasserer A, Rokohl AC, Liu H, Mestanoglu M, Kashkar H, Schumacher B, Kiefer F, Schulte-Merker S, Matthaei M, Hou Y, Fassbender S, Jantsch J, Zhang W, Enders P, Bachmann B, Bock F, Cursiefen C. The novel role of lymphatic vessels in the pathogenesis of ocular diseases. Prog Retin Eye Res. 2023 Sep;96:101157. doi:10.1016/j.preteyeres.2022.101157. Epub 2023 Feb 8. PMID: 36759312.
  4. Schlereth SL, Gietzelt C, Zwingelberg S, Matthaei M, Bachmann B, Cursiefen C. Chirurgische Therapieoptionen bei kongenitalen/kindlichen Hornhauttrübungen und Vorderabschnittsdysgenesien [Surgical treatment options for congenital/infantile corneal opacities and anterior segment dysgenesis]. Ophthalmologe. 2022 May;119(5):453-461. German.
  5. Peil J, Bock F, Kiefer F, Schmidt R, Heindl LM, Cursiefen C, Schlereth SL: New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. Int J Mol Sci. 2022 Jan 27;23(3):1478
  6. Hos D, Schlereth S, Schrittenlocher S, Hayashi T, Bock F, Matthaei M, Bachmann BO, Cursiefen C.: [Descemet membrane endothelial keratoplasty (DMEK) for graft failure after penetrating keratoplasty and in vascularized high-risk eyes]. Ophthalmologe. 2021 Jun;118(6):536-543.
  7. Schlereth SL and Schrittenlocher S, Siebelmann S, Hayashi T, Matthaei M, Bachmann B, Cursiefen C.: Long-term outcome of descemet membrane endothelial keratoplasty (DMEK) following failed penetrating keratoplasty. Acta Ophthalmol. 2020 Mar 20. doi: 10.1111/aos.14417
  8. Schlereth SL, Karlstetter M, Hos D, Matthaei M, Cursiefen C, Heindl LM.: Detection of Pro- andAntiangiogenic Factors in the Human Sclera. Curr. Eye Res. 2019 Feb;44(2):172-184.
  9. Schlereth SL, Hos D, Matthaei M., Hos D, Matthaei M, Hamrah P, Schmetterer L, O’Leary O, Ullmer C, Horstmann J, Bock F, Wacker K, Schröder H, Notara M, Haagdorens M, Nuijts RMMA, Dunker S, Dickman M, Fauser S, Scholl HPN, Wheeler-Schilling T, Cursiefen C.: New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Defiency – Review from the European Vision Institute (EVI) Special Interest Focus Group Meeting. Ophthalmic Research. 2021; 64(2):145-167. Review